Effects of 9cis,11trans and 10trans,12cis CLA on osteoclast formation and activity from human CD14+ monocytes

Lipids in Health and Disease

Volumn 8, Issue , 2009, Pages

  Platt, Ilana ^a   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; CONJUGATED LINOLEIC ACID; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; 10,12 OCTADECADIENOIC ACID; 10,12-OCTADECADIENOIC ACID; 9,11 LINOLEIC ACID; 9,11-LINOLEIC ACID; CATHEPSIN; CD14 ANTIGEN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CELL SUBPOPULATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ISOMER; MONOCYTE; NORMAL HUMAN; OSTEOCLAST; OSTEOLYSIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; STEREOISOMERISM;

ANIMALIA; MURINAE;

ANTIGENS, CD14; BONE RESORPTION; CATHEPSINS; GENE EXPRESSION REGULATION; HUMANS; LINOLEIC ACIDS, CONJUGATED; MATRIX METALLOPROTEINASE 9; MONOCYTES; OSTEOCLASTS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STEREOISOMERISM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65649149046     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-8-15     Document Type: Article

References (43)

1. Effect of conjugated linoleic acid on body composition in mice. Y Park KJ Albright W Liu JM Storkson ME Cook MW Pariza, Lipids 1997 32 8 853 858 10.1007/s11745-997-0109-x 9270977 (Pubitemid 27360392)
2. Broilers fed conjugated linoleic acid had enhanced bone ash. ME Cook DL Jerome M Pariza, Poult Sci 1997 76 162
3. Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. BA Watkins Y Li HE Lippman S Feng, Prostaglandins Leukot Essent Fatty Acids 2003 68 387 398 10.1016/S0952-3278(03)00063-2 12798659 (Pubitemid 36724030)
4. Dietary conjugated linoleic acids alter serum IGF-1 and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. Y Li MF Seifert DM Ney M Grahn AL Grant KGD Allen BA Watkins, J Bone Miner Res 1999 14 1153 1162 10.1359/jbmr.1999.14.7.1153 10404015 (Pubitemid 29314058)
5. Conjugated linoleic acid protects against age-associated bone loss in C57BL/6 female mice. MM Rahman A Bhattacharya J Banu G Fernandes, J Nutr Biochem 2007 18 7 467 474 10.1016/j.jnutbio.2006.08.002 16997541 (Pubitemid 46874920)
6. Dietary lipids modulate bone prostaglandin E2 production, insulin-like growth factor-1 concentration and formation rate in chicks. BA Watkins CL Shen JP McMurty H Xu SD Bain KG Allen MF Seifert, J Nutr 1997 127 1084 1091 9187621 (Pubitemid 27242105)
7. Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice. J Banu A Bhattacharya M Rahman M O'Shea G Fernandes, Lipids Health Dis 2006 5 7 16556311 10.1186/1476-511X-5-7
8. Conjugated linoleic acids alter bone fatty acid composition and reduce ex vivo prostaglandin E 2 biosynthesis in rats fed n-6 or n-3 fatty acids. Y Li BA Watkins, Lipids 1998 33 417 425 10.1007/s11745-998-0223-9 9590630 (Pubitemid 28217388)
9. The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats. O Kelly S Cusack C Jewell KD Cashman, Br J Nutr 2003 90 743 750 10.1079/BJN2003951 13129442 (Pubitemid 37270756)
10. Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. RA Brownbill M Petrosian JZ Ilich, J Am Coll Nutr 2005 24 177 181 15930483 (Pubitemid 41201960)
11. The effect of conjugated linoleic acid on calcium absorption and bone metabolism and composition in adult ovariectomised rats. O Kelly KD Cashman, Prostaglandins Leukot Essent Fatty Acids 2004 71 295 301 10.1016/j.plefa.2004. 04.003 15380816 (Pubitemid 39233553)
12. Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats. H Weiler S Austin S Fitzpatrick-Wong E Nitschmann N Bankovic-Calic R Mollard H Aukema M Ogborn, Am J Clin Nutr 2004 79 1186S 1189S 15159255
13. Effect of dietary supplementation with conjugated linoleic acid on markers of calcium and bone metabolism in healthy adult men. L Doyle C Jewell A Mullen AP Nugent HM Roche KD Cashman, Eur J Clin Nutr. 2005 59 3 432 440 10.1038/sj.ejcn.1602093 15674313 (Pubitemid 40403299)
14. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling. MM Rahman A Bhattacharya G Fernandes, J Lipid Res 2006 47 8 1739 1748 10.1194/jlr.M600151-JLR200 16702601 (Pubitemid 44222825)
15. Isomer-specific effects of conjugated linoleic acid on mineralized bone nodule formation from human osteoblast-like cells. I Platt LG Rao A El-Sohemy, Exp Biol Med (Maywood) 2007 232 2 246 252 17259332 (Pubitemid 46203293)
16. The effect of conjugated linoleic acid on the viability and metabolism of human osteoblast-like cells. S Cusack C Jewell KD Cashman, Prostaglandins Leukot Essent Fatty Acids 2005 72 29 39 10.1016/j.plefa.2004.09.002 15589397 (Pubitemid 39626785)
17. Therapeutic approaches to bone diseases. GA Rodan TJ Martin, Science 2000 289 5484 1508 1514 10.1126/science.289.5484.1508 10968781
18. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. TL Burgess Y Qian S Kaufman BD Ring G Van C Capparelli M Kelley H Hsu WJ Boyle CR Dunstan, J Cell Biol 1999 145 3 527 538 10225954 10.1083/jcb.145.3.527 (Pubitemid 29215717)
19. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. DL Lacey E Timms HL Tan MJ Kelley CR Dunstan T Burgess R Elliott A Colombero G Elliott S Scully, Cell 1998 93 2 165 176 10.1016/S0092-8674(00)81569-X 9568710 (Pubitemid 28180851)
20. The cell biology of osteoclast function. HK Vaananen H Zhao M Mulari JM Halleen, J Cell Sci 2000 113 Pt 3 377 381 10639325 (Pubitemid 30116644)
21. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. FH Drake RA Dodds IE James JR Connor C Debouck S Richardson E Lee-Rykaczewski L Coleman D Rieman R Barthlow, J Biol Chem 1996 271 21 12511 12516 10.1074/jbc.271.21.12511 8647859 (Pubitemid 26160923)
22. Identification of matrix metalloproteinase 9 in rabbit osteoclasts. K Tezuka K Nemoto Y Tezuka T Sato Y Ikeda M Kobori H Kawashima H Eguchi Y Hakeda M Kumegawa, J Biol Chem 1994 269 21 15006 15009 8195136 (Pubitemid 24198341)
23. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. JM Halleen H Ylipahkala SL Alatalo AJ Janckila JE Heikkinen H Suominen S Cheng HK Vaananen, Calcif Tissue Int 2002 71 1 20 25 10.1007/s00223-001-2122-7 12073156 (Pubitemid 36934772)
24. The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone. JJ Stepan J Pospichal V Schreiber J Kanka J Mensik J Presl V Pacovsky, Calcif Tissue Int 1989 45 5 273 280 10.1007/BF02556018 2509014 (Pubitemid 19271418)
25. Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior. B Kirstein TJ Chambers K Fuller, J Cell Biochem 2006 98 5 1085 1094 10.1002/jcb.20835 16475168 (Pubitemid 44128351)
26. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. DM Anderson E Maraskovsky WL Billingsley WC Dougall ME Tometsko ER Roux MC Teepe RF DuBose D Cosman L Galibert, Nature 1997 390 6656 175 179 10.1038/36593 9367155 (Pubitemid 27507987)
27. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. BR Wong J Rho J Arron E Robinson J Orlinick M Chao S Kalachikov E Cayani FS Bartlett 3rd WN Frankel, J Biol Chem 1997 272 40 25190 25194 10.1074/jbc.272.40.25190 9312132 (Pubitemid 27415705)
28. The vital osteoclast: how is it regulated? D Aeschlimann BA Evans, Cell Death Differ 2004 11 Suppl 1 S5 7 10.1038/sj.cdd.4401470 15243577 (Pubitemid 39136790)
29. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. W Zou I Hakim K Tschoep S Endres Z Bar-Shavit, J Cell Biochem 2001 83 1 70 83 10.1002/jcb.1202 11500955 (Pubitemid 32835003)
30. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. BM Thomson GR Mundy TJ Chambers, J Immunol 1987 138 3 775 779 3805716 (Pubitemid 17012392)
31. Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H] tetracycline excretion from prelabeled mice. A Konig RC Muhlbauer H Fleisch, J Bone Miner Res 1988 3 6 621 627 3266953 (Pubitemid 19042548)
32. Conjugated linoleic acid supplementation reduces peripheral blood mononuclear cell interleukin-2 production in healthy middle-aged males. A Mullen F Moloney AP Nugent L Doyle KD Cashman HM Roche, J Nutr Biochem 2007 18 10 658 666 10.1016/j.jnutbio.2006.12.008 17368881 (Pubitemid 47385158)
33. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Y Yu PH Correll JP Vanden Heuvel, Biochim Biophys Acta 2002 1581 3 89 99 12020636 (Pubitemid 34521887)
34. Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decreased production of adiponectin and leptin. A Ohashi Y Matsushita K Kimura K Miyashita M Saito, J Nutr Sci Vitaminol (Tokyo) 2004 50 6 416 421 15895517 (Pubitemid 40502534)
35. Dietary supplementation with conjugated linoleic acid increased its concentration in human peripheral blood mononuclear cells, but did not alter their function. DS Kelley VA Simon PC Taylor IL Rudolph P Benito GJ Nelson BE Mackey KL Erickson, Lipids 2001 36 7 669 674 10.1007/s11745-001-0771-z 11521964 (Pubitemid 32777011)
36. Conjugated linoleic acids exert similar actions on prostanoid release from aortic and coronary artery smooth muscle cells. R Ringseis S Gahler C Herter K Eder, Int J Vitam Nutr Res 2006 76 5 281 289 10.1024/0300-9831.76.5.281 17245666 (Pubitemid 46253641)
37. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma. E Graves A Hitt MW Pariza ME Cook DO McCarthy, Res Nurs Health 2005 28 1 48 55 10.1002/nur.20052 15625711 (Pubitemid 40223377)
38. Advances in bone biology: the osteoclast. GD Roodman, Endocr Rev 1996 17 4 308 332 8854048 (Pubitemid 26277978)
39. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. JM Gaullier J Halse HO Hoivik K Hoye C Syvertsen M Nurminiemi C Hassfeld A Einerhand M O'Shea O Gudmundsen, Br J Nutr 2007 97 3 550 560 10.1017/S0007114507381324 17313718 (Pubitemid 46662046)
40. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. RB Kreider MP Ferreira M Greenwood M Wilson AL Almada, J Strength Cond Res 2002 16 325 334 10.1519/1533-4287(2002)016<0325:EOCLAS>2.0.CO;2 12173945
41. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. JM Gaullier J Halse K Hoye K Kristiansen H Fagertun H Vik O Gudmundsen, J Nutr 2005 135 4 778 784 15795434 (Pubitemid 40464104)
42. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. JM Gaullier J Halse K Hoye K Kristiansen H Fagertun H Vik O Gudmundsen, Am J Clin Nutr 2004 79 6 1118 1125 15159244 (Pubitemid 41095966)
43. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration. I Voronov JN Heersche RF Casper HC Tenenbaum MF Manolson, Biochem Pharmacol 2005 70 2 300 307 10.1016/j.bcp.2005.04.028 15919055 (Pubitemid 40814411)